Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

UroGen Pharma (URGN) Debt Ratio (2022 - 2025)

Historic Debt Ratio for UroGen Pharma (URGN) over the last 4 years, with Q3 2025 value amounting to 0.66.

  • UroGen Pharma's Debt Ratio rose 6371.08% to 0.66 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.66, marking a year-over-year increase of 6371.08%. This contributed to the annual value of 0.43 for FY2024, which is 2290.93% down from last year.
  • Per UroGen Pharma's latest filing, its Debt Ratio stood at 0.66 for Q3 2025, which was up 6371.08% from 0.59 recorded in Q2 2025.
  • UroGen Pharma's Debt Ratio's 5-year high stood at 1.03 during Q2 2023, with a 5-year trough of 0.35 in Q2 2024.
  • Its 4-year average for Debt Ratio is 0.57, with a median of 0.51 in 2023.
  • Its Debt Ratio has fluctuated over the past 5 years, first skyrocketed by 11158.34% in 2023, then plummeted by 6633.22% in 2024.
  • Quarter analysis of 4 years shows UroGen Pharma's Debt Ratio stood at 0.72 in 2022, then decreased by 23.15% to 0.55 in 2023, then fell by 22.91% to 0.43 in 2024, then surged by 54.88% to 0.66 in 2025.
  • Its Debt Ratio was 0.66 in Q3 2025, compared to 0.59 in Q2 2025 and 0.49 in Q1 2025.